Human intelligence enhanced by artificial intelligence

A revolution in structural heart identification and management

How do you know if a severe patient has been missed?

What if your moderate patients don’t progress at the same rate ? 

What if your moderate patients don’t progress at the same rate ?

How do you know if a severe patient has been missed?

Human intelligence enhanced by artificial intelligence

A revolution in structural heart identification and management

The Solution   

Improving Outcomes

This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.

The Leading Solution to Manage Patients with Structural Heart Disease

Aortic
Stenosis

Mitral
Stenosis

Tricuspid Regurgitation

Aortic Regurgitation

Mitral Regurgitation

Aortic
Stenosis

Aortic
Regurgitation

Mitral
Stenosis

Mitral
Regurgitation

Tricuspid Regurgitation

Overview  

The CardioCare Program

Providing a comprehensive view of structural heart patients to close gaps in care, now helping physicians identify the most at-risk patients. This leading-edge combination of software and services powers insights that close gaps that can cause undertreatment in structural heart disease.

+37%

+29%

+35%

+54%

**Analysis represents aggregate median performance across 14 sites with baseline data after six months of using the CardioCare program.

The Solution   

Improving Outcomes

This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.

Introducing Our New Predictive Suite

The Challenge 

Gaps in Care that Can Lead to Delays in Treatment

Overview

How It Works

The CardioCare program is the industry leader in structural heart data analytics and clinical process improvement, reducing variability in diagnoses and improving
guideline-directed treatment by focusing on:

Diagnostic
Precision

Predict the likelihood that a patient has been undiagnosed with severe AS

Care Pathway Optimization

Automatically identify and manage all SHD patients to ensure patients receive timely treatment

Disease
Progression

Predict the likelihood a moderate AS patient will progress to severe disease

                 * This product is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of structural heart diseases.

Testimonials

Leading hospitals partner with egnite’s CardioCare program to reduce variability in diagnoses and improve guideline-directed therapy for patients with structural heart disease.

Implementing CardioCare has been a powerful win-win; it’s been a win for our hospital, for our program and for our echo labs, but really, it’s been a win for our patients.
Dr. Maddie Petrescu
Director, Echocardiography Laboratory Swedish Heart and Vascular
Swedish Medical Center
This is the first time in my career I've been able to see this type of information for my program. There is always opportunity to improve, even at academic medical institutions. CardioCare is not just a platform; it's a program that can demonstrate value for structural heart programs at every level.
Dr. Rahul Sharma
Assistant Professor of Medicine, Stanford University
Director of Structural Interventions, Stanford Health Care
CardioCare’s advanced technology provides a data-driven approach to assessing our structural heart patient population, helping us identify patients at risk and provide the care they need throughout the Northwestern Medicine system.
Dr. Patrick McCarthy
Executive Director, Bluhm Cardiovascular Institute
Vice President Northwestern Medical Group Chief, Division of Cardiac Surgery

Resources

Connect with egnite.

Set up a free demo today.